Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fumito Onogi is active.

Publication


Featured researches published by Fumito Onogi.


Journal of Clinical Biochemistry and Nutrition | 2012

Combination of proton pump inhibitor and rebamipide, a free radical scavenger, promotes artificial ulcer healing after endoscopic submucosal dissection with dissection size >40 mm

Hiroshi Araki; Tomohiro Kato; Fumito Onogi; Takashi Ibuka; Akihiko Sugiyama; Takayuki Nakanishi; Tomohiko Sugiyama; Eiichi Tomita; Hisataka Moriwaki

In our previous study, the healing effect of proton pump inhibitor plus rebamipide for endoscopic submucosal dissection-related artificial ulcer smaller than 40 mm showed statistical significance. However, such effect of the combination was not yet clear for ulcers with dissected diameter more than 40 mm. The aim of this present study was to resolve this problem under sufficient statistical power, with adequate sample size. We conducted a randomized controlled study. Either the proton pump inhibitor mono-therapy or the combination therapy was prescribed for 28 days after endoscopic submucosal dissection. Eighty-seven patients were eligible for outcome evaluation. Combination therapy was significantly superior to mono-therapy, 27.8% vs 0% reached healing stage (scar stage) in cases with ulcers of dissection diameter more than 40 mm. In conclusion, the combination therapy with rebamipide was favorable regimen in patients with larger artificial ulcer after endoscopic submucosal dissection.


World Journal of Gastroenterology | 2015

Safety and efficacy of carbon dioxide insufflation during gastric endoscopic submucosal dissection

Jun Takada; Hiroshi Araki; Fumito Onogi; Takayuki Nakanishi; Masaya Kubota; Takashi Ibuka; Masahito Shimizu; Hisataka Moriwaki

AIM To compare the safety and efficacy of carbon dioxide (CO2) and air insufflation during gastric endoscopic submucosal dissection (ESD). METHODS This study involved 116 patients who underwent gastric ESD between January and December 2009. After eliminating 29 patients who fit the exclusion criteria, 87 patients, without known pulmonary dysfunction, were randomized into the CO2 insufflation (n = 36) or air insufflation (n = 51) groups. Standard ESD was performed with a CO2 regulation unit (constant rate of 1.4 L/min) used for patients undergoing CO2 insufflation. Patients received diazepam for conscious sedation and pentazocine for analgesia. Transcutaneous CO2 tension (PtcCO2) was recorded 15 min before, during, and after ESD with insufflation. PtcCO2, the correlation between PtcCO2 and procedure time, and ESD-related complications were compared between the two groups. Arterial blood gases were analyzed after ESD in the first 30 patients (12 with CO2 and 18 with air insufflation) to assess the correlation between arterial blood CO2 partial pressure (PaCO2) and PtcCO2. RESULTS There were no differences in respiratory functions, median sedative doses, or median procedure times between the groups. Similarly, there was no significant difference in post-ESD blood gas parameters, including PaCO2, between the CO2 and air groups (44.6 mmHg vs 45 mmHg). Both groups demonstrated median pH values of 7.36, and none of the patients exhibited acidemia. No significant differences were observed between the CO2 and air groups with respect to baseline PtcCO2 (39 mmHg vs 40 mmHg), peak PtcCO2 during ESD (52 mmHg vs 51 mmHg), or median PtcCO2 after ESD (50 mmHg vs 50 mmHg). There was a strong correlation between PaCO2 and PtcCO2 (r = 0.66; P < 0.001). The incidence of Mallory-Weiss tears was significantly lower with CO2 insufflation than with air insufflation (0% vs 15.6%, P = 0.013). CO2 insufflation did not cause any adverse events, such as CO2 narcosis or gas embolisms. CONCLUSION CO2 insufflation during gastric ESD results in similar blood gas levels as air insufflation, and also reduces the incidence of Mallory-Weiss tears.


Endoscopy International Open | 2014

Risk factors for pyrexia after endoscopic submucosal dissection of gastric lesions.

Takayuki Nakanishi; Hiroshi Araki; Noritaka Ozawa; Jun Takada; Masaya Kubota; Kenji Imai; Fumito Onogi; Takashi Ibuka; Makoto Shiraki; Masahito Shimizu; Hisataka Moriwaki

Background and study aims: Endoscopic submucosal dissection (ESD) is widely used in the resection of gastric tumors en bloc, however, complications such as pyrexia frequently occur following the procedure. The study aim was to elucidate the incidence, clinical characteristics, and risk factors of post-ESD pyrexia. Patients and methods: We conducted a retrospective cohort study of 471 consecutive patients with 485 gastric lesions resected by ESD between December 2005 and 2010. Pyrexia was defined as body temperature above 37.5 °C, regardless of its duration. Blood tests and chest radiography were performed three times before and after ESD. Chest and abdominal computed tomography (CT) was taken on postoperative day 1. Results: Post-ESD pyrexia developed in 117 patients (24.8 %), including 40 patients with pneumonia as shown by computed tomography. The pyrexia was resolved in all the patients after 1 day (median; range, 1 – 36 days). A multivariate analysis identified age (P = 0.0029) and resection diameter (P = 0.0009) as risk factors for pyrexia in patients without pneumonia, and operation time (P = 0.0025) as a risk factor for pyrexia in patients with pneumonia. Conclusion: The patient would be at risk for post-ESD pyrexia if a large ESD is performed in the elderly. The longer operation time would raise the risk for pneumonia-associated fever.


World Journal of Gastrointestinal Endoscopy | 2013

Diagnosis of the jejunoileal lymphoma by double-balloon endoscopy.

Takashi Ibuka; Hiroshi Araki; Tomohiko Sugiyama; Takayuki Nakanishi; Fumito Onogi; Masahito Shimizu; Takeshi Hara; Tsuyoshi Takami; Hisashi Tsurumi; Hisataka Moriwaki

AIM To investigate the feasibility of double-balloon endoscopy (DBE) to detect jejunoileal lymphoma, compared with fluorodeoxyglucose positron emission tomography (FDG-PET). METHODS Between March 2004 and January 2011, we histologically confirmed involvement of malignant lymphoma of the jejunoileum in 31 patients by DBE and biopsy. In 20 patients of them, we performed with FDG-PET. We retrospectively reviewed the records of these 20 patients. Their median age was 64 years (range 50-81). In the 20 patients, the pathological diagnosis of underlying non-Hodgkins lymphoma (NHL) comprised follicular lymphoma (FL, n = 12), diffuse large B cell lymphoma (DLBCL, n = 4), mantle cell lymphoma (MCL, n = 2), enteropathy associated T cell lymphoma (ETL, n = 1) and anaplastic large cell lymphoma (ALCL, n = 1). RESULTS Ten cases showed accumulation by FDG-PET (50%). FDG-PET was positive in 3 of 12 FL cases (25%) while in 7 of 8 non-FL cases (88%, P < 0.05). Intestinal FL showed a significantly lower rate of positive FDG-PET, in comparison with other types of lymphoma. Cases with endoscopically elevated lesions (n = 10) showed positive FDG-PET in 2 (20%), but those with other type NHL did in 8 of 10 (80%, P < 0.05). When the cases having elevated type was compared with those not having elevated type lesion, the number of cases that showed accumulation of FDG was significantly smaller in the former than in the latter. CONCLUSION In a significant proportion, small intestinal involvement cannot be pointed out by FDG-PET. Especially, FL is difficult to evaluate by FDG-PET but essentially requires DBE.


Journal of Gastroenterology | 2010

Clinical trial : rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection-a randomized controlled study

Tomohiro Kato; Hiroshi Araki; Fumito Onogi; Takashi Ibuka; Akihiko Sugiyama; Eiichi Tomita; Masahito Nagaki; Hisataka Moriwaki


Surgical Endoscopy and Other Interventional Techniques | 2015

Safety of carbon dioxide insufflation during gastric endoscopic submucosal dissection in patients with pulmonary dysfunction under conscious sedation

Jun Takada; Hiroshi Araki; Fumito Onogi; Takayuki Nakanishi; Masaya Kubota; Takashi Ibuka; Masahito Shimizu; Hisataka Moriwaki


The Japanese journal of gastro-enterology | 2010

[A Japanese family with adult-onset familial Mediterranean fever and periodic episodes of high fever and abdominal pain].

Hiroshi Araki; Fumito Onogi; Takashi Ibuka; Hisataka Moriwaki


International Journal of Hematology | 2013

Clinical significance of jejunoileal involvement of non-Hodgkin's lymphoma detected by double-balloon enteroscopy

Takashi Ibuka; Hisashi Tsurumi; Hiroshi Araki; Takeshi Hara; Fumito Onogi; Naoe Goto; Yasushi Kojima; Nobuhiro Kanemura; Makoto Shiraki; Senji Kasahara; Masahito Shimizu; Kengo Ogawa; Soranobu Ninomiya; Takayuki Nakanishi; Tomohiro Kato; Tsuyoshi Takami; Hisataka Moriwaki


Gastrointestinal Endoscopy | 2011

Sa1676 Endoscopic Examination of Synchronous or Metachronous Multiple Gastric Tumors After the Initial Endoscopic Submucosal Dissection for Early Gastric Cancer or Gastric Adenoma

Tomohiro Kato; Hiroshi Araki; Fumito Onogi; Takashi Ibuka; Akihiko Sugiyama; Eiichi Tomita; Hisataka Moriwaki


Gastrointestinal Endoscopy | 2011

Sa1552 Frequency of Superficial Esophageal Adenocarcinoma in Patients Performed ESD for Upper Gastrointestinal Tract Lesions, and Comparison of Clinicopathological Characteristics in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Central Japan

Hiroshi Araki; Takayuki Nakanishi; Fumito Onogi; Takashi Ibuka; Tomohiro Kato; Hisataka Moriwaki

Collaboration


Dive into the Fumito Onogi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomohiro Kato

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge